Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
J Clin Oncol
; 41(35): 5400-5410, 2023 Dec 10.
Article
in En
| MEDLINE
| ID: mdl-37669480
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Endometrial Neoplasms
/
Hydrazines
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
J Clin Oncol
Year:
2023
Document type:
Article
Affiliation country:
Belgium